OBJECTIVES: Acute kidney injury can occur after cardiac catheterization and cardiac surgery. The negative effects of the contrast media and cardiopulmonary bypass on renal function may be additive when performed in close succession. The results in the literature are, however, conflicting.
INTRODUCTION
Acute kidney injury (AKI) can occur after both cardiac surgical procedures (up to 30%) [1, 2] and cardiac catheterization (up to 10%) [3] . The most recent ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (2011) recommends a delay in surgery after coronary angiography in patients with pre-existing renal dysfunction [4] .
AKI after cardiac surgery occurs as a result of the consecutive events of hypoperfusion, oxidative injury and ischaemic injury. Cardiopulmonary bypass (CPB) induces haemodynamic changes and inflammatory responses, leading to hypoperfusion and oxidative injury. Haemodilution, hypothermia and the absence of pulsatile flow further increase the chance of regional renal ischaemia and cellular injury that may lead to AKI [2] . The pathogenesis of radiocontrast nephropathy also appears to be multifactorial and includes a deleterious reduction in renal arteriolar blood flow and glomerular filtration rate, as well as the direct renal tubular toxicity caused by the radiocontrast agents [5] . Estimated glomerular filtration rate <60 ml min −1 1.73 m −2 , diabetes mellitus, volume depletion, haemodynamic instability, major comorbidities and anaemia are among the major risk factors for the development of AKI after cardiac catheterization. The effects of risk factors are shown to be additive, so the higher the number of risk factors, the higher the likelihood of contrast-induced AKI [6, 7] . It can be hypothesized that the deleterious effects of contrast used during cardiac catheterization and CPB on renal function may also be additive when performed in close succession. There has been no clear evidence of a specific period after catheterization that would be safe for further interventions without causing damage to renal function. The purpose of this investigation was to assess the effect of two consecutive deleterious procedures on renal function and its clinical implications.
MATERIALS AND METHODS
This study was approved by the Human Studies and Research Committee of our institution; individual patient consent was waived, as all data were reviewed retrospectively. A total of 636 patients underwent cardiac surgical procedures at our institution between December 2010 and December 2012. Sixty-three patients who had incomplete data, those referred from other hospitals for surgery, those who were receiving preoperative dialysis and those who had off-pump coronary artery bypass graft (CABG) operations were excluded. A total of 573 patients were included in the final analysis. All the patients underwent a standard preoperative cardiac catheterization at our hospital. Iomeron 400 solution (Iomeprol; Bracco, Milan, Italy), a non-ionic, monomeric iodinated contrast medium with low chemotoxicity, osmolality and viscosity and high water solubility, containing iomeprol equivalent to 400 mg ml −1 of iodine, was used in the studies. In our cardiology department, the rotational coronary angiography technique is used as a standard method for all the diagnostic catheterizations. This acquisition method uses automated gantry movements; numerous angiographic projections are obtained in a single image, which reduces the number of images and amount of contrast required for a complete workup. A total of 40-60 ml of contrast agent per study was used in almost all the patients in this study. We were unable to collect data on the exact volumes of contrast used for the studies since they were not recorded. Nevertheless, the cardiologists did not report excess use of contrast material in any of our patients.
Data on all patient demographics, clinical characteristics, comorbid conditions, laboratory results, perioperative and postoperative events and surgical data were collected prospectively in a computerized database for all the patients who underwent cardiac surgery at our institution. Predicted mortality was calculated for each patient using the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II risk model [8] .
The primary outcome variable was development of AKI after cardiac surgery as defined by the AKI Network (an absolute increase of ≥26.5 μmol l −1 or a relative increase of ≥50% in serum creatinine level from baseline value within 48 h of surgery, or requiring postoperative haemodialysis) [9] . The patients were separated into three groups according to the time between catheterization and surgery as follows: Group A, ≤1 day (n = 69); Group B, >1 and ≤5 days (n = 216) and Group C, >5 days (n = 288). The 0 and 1 day group (Group A) was selected to identify higherrisk patients who required emergency surgery. Contrast-induced AKI is typically defined as reaching a peak up to 5 days after the catheterization [6] . The 5-day interval was selected to include this peak (Group B).
Statistical analysis
Statistical analysis was performed with the IBM® SPSS® Statistics 20.0 software (IBM, Corp., Chicago, IL, USA 
RESULTS

Patient data
The preoperative demographics of the 3 groups of 573 patients who underwent cardiac surgery are presented in Table 1 . Most of the patients underwent CABG only (81%). The patients in Group A, which included mostly emergency surgery, had higher New York Heart Association Class (P = 0.0001) and higher EuroSCORE II mortality risk (P = 0.01). Incidence of previous myocardial infarction (MI) was also significantly higher in Group A (P = 0.005). Conversely, Group C comprised patients with a higher percentage of left ventricular dysfunction (LVD; P = 0.01). In addition, this group of patients had lower haematocrit levels (P = 0.008) and a significantly higher incidence of elevated preprocedural creatinine levels (serum creatinine >106 μmol l −1 ) (P = 0.03) than Groups A and B combined. This is probably related to the longer preparation time for surgery in these patients and the intentional delay for patients in a stable condition after recent MI and LVD.
Operative and postoperative data for each group are given in Table 2 .
Primary outcomes
AKI was detected in 233 patients (41%). Eight patients (1%) required haemodialysis postoperatively, 6 (75%) of whom died during the early postoperative period. There was no significant difference between the patients with and those without AKI in relation to the time from catheterization to surgery (P = 0.09). Although the incidence of AKI was slightly higher in Group C, this difference was not statistically significant (P = 0.67).
The effect of time between cardiac catheterization and cardiac operation on postoperative AKI was further examined by separate logistic regression models of periods in 0-1, 0-2, 0-4, 0-6, 0-10 days and 0 to ≥11 days before the operation (Table 3 ). There was a very slight increased risk of developing AKI in 0-2 days but none of the time periods was found to be statistically significant. The risk of developing AKI seems to be neither reduced nor increased by increasing time from catheterization to operation. Furthermore, there was no significant relation in the time from catheterization to operation and AKI in patients with elevated preprocedural creatinine levels (>106 μmol l −1 , P = 0.23), LVD (ejection fraction [EF] <40%, P = 0.19) and older age (≥70 years, P = 0.86).
Secondary outcomes
The results of the bivariate analysis of demographic and perioperative factors associated with the development of AKI after cardiac surgery are given in during CPB was significantly associated with AKI (P = 0.006). The longer durations of cross-clamp and CPB and the lower minimum mean arterial pressure during CPB were found to be significantly related to the development of postoperative AKI (P = 0.005, P = 0.0001 and P = 0.004, respectively). Multivariate analysis of the variables with bivariate significance showed older age (P = 0.01), longer CPB time (P = 0.003), higher body mass index (BMI, kg m −2 ; P = 0.001) and lower preoperative haematocrit (P = 0.02) to be independently associated with development of AKI (Table 5 ; c-statistic = 0.658, Hosmer-Lemeshow χ 2 = 13.24, degrees of freedom = 8, P = 0.104). Although increased amounts of colloid infusion and packed red blood cell (PRBC) transfusion, lower haematocrit levels on CPB, excess perioperative blood drainage, longer cross-clamp time and lower mean arterial pressure on CPB were noted in the bivariate analysis, none of these variables was found to be significantly associated with development of AKI in the logistic regression model.
Overall postoperative hospital mortality was 4.4%. Mortality was not significantly different between the three groups of time from catheterization (P = 0.15); however, it was significantly increased in the patients with AKI (P = 0.001). Bivariate analysis of the variables age (P = 0.001), diabetes mellitus (P = 0.04), elevated preoperative creatinine levels (>106 μmol l −1 ; P < 0.0001), longer cross-clamp (P < 0.0001) and CPB times (P < 0.0001), presence of AKI (P = 0.001), lowest haematocrit level measured on CPB (P = 0.01), increased amounts of perioperative blood drainage (P = 0.004) and PRBC transfusion (P < 0.0001) and total perioperative colloid infusion (P = 0.008) showed significant associations of these factors with mortality. However, in the multivariate logistic regression analysis, elevated preoperative creatinine levels (>106 μmol l −1 ) were associated with a more than 5-fold increase in mortality (OR, 5.39; 95% CI, 1.99-14.63; P = 0.001) followed by almost a 3-fold increase in the presence of AKI (OR, 2.96; 95% CI, 1.14-7.69; P = 0.03). Other independent predictors for mortality were presence of diabetes mellitus (OR, 2.74; 95% CI, 1.11-6.78; P = 0.03), increasing amounts of perioperative PRBC transfusion (OR, 1.68; 95% CI, 1.24-2.28; P = 0.001) and older age (OR, 1.06; 95% CI, 1.01-1.11; P = 0.02) (c-statistic = 0.844, Hosmer-Lemeshow χ 2 = 6.56, degrees of freedom = 8, P = 0.59).
DISCUSSION
Our study showed that the time between cardiac catheterization and cardiac surgery was not a significant risk factor for the occurrence of AKI. Even after extensive statistical analysis, there was no significant correlation between any of the groups, according to the time between cardiac catheterization and operation, and the development of AKI.
There are contradicting reports regarding the association between AKI and the time between angiography and cardiac surgery. Del Duca et al. [10] concluded that cardiac catheterization performed within 5 days before the operation is a significant risk factor for acute renal failure after cardiac surgery. Medalion et al.
[11] also suggested that CABG should be delayed by at least 5 days in patients who receive a high contrast dose. Their results showed that an operation performed within 24 h of catheterization was an independent predictor of postoperative acute renal failure [11] . Similar to Hennessy et al. [12] , Ranucci et al. [13] reported that surgery performed on the same day as angiography is a risk factor for acute renal failure. However, in those reports, patients who underwent surgery close to the time of angiography and developed acute renal failure had more preoperative risk factors for postoperative acute renal failure. In contrast, in the present study, Group C included more patients with elevated preoperative creatinine levels and other risk factors for postoperative acute renal failure as a result of our institutional policy of delaying surgery in these patients.
There are other studies supporting our results. Ko et al. [14] noted that the time interval between coronary angiogram and cardiac surgery did not affect the risk of AKI after cardiac surgery. Brown et al. [15] suggested that same-day angiography may be safe in a select population of valve surgery patients. Greason et al. [16] further supported these findings and concluded that in select patients with a low risk of AKI, same-day angiography was not associated with increased morbidity, AKI or death. In the present study, we performed separate regression analysis comparing various ranges of time intervals and overall days to explore the effect of time from catheterization to operation on the development of postoperative AKI; however, there was no significant risk of developing AKI, even at 10 days.
In most studies, age, LVD, diabetes mellitus, peripheral vascular disease, preoperative use of an intra-aortic balloon pump, chronic obstructive pulmonary disease, emergency surgery and elevated preoperative creatinine levels are commonly associated with increased risk of AKI [2, 10, 12, 14, [17] [18] [19] . In the present study, age, BMI, preoperative haematocrit and CPB time were among the factors significantly associated with AKI. Although an elevated preoperative creatinine level (>106 μmol l ) was not significantly associated with AKI in our patient group, it was significantly associated with mortality. The main limitation of this study is its retrospective observational design. Our study cohort included patients with various risks and different types of operations, reflecting our daily clinical experience. However, patients with prominent chronic kidney failure and those receiving preoperative dialysis were excluded to express a new renal insult. Furthermore, widely accepted and sensitive AKI network criteria have been used to define AKI. High-risk patients with elevated creatinine levels are managedcomplying with the guidelines-through proper hydration, discontinuation of nephrotoxic agents and optimization of renal functions before the operation. These patients had a longer time interval between catheterization and operation and were predominantly present in Group C. This bias in our study may be an advantage, since our practice filters out the high-risk patients. Consequently, the low-and medium-risk patients could be studied to obtain clearer evidence on the effect of time between catheterization and operation. Another limitation is the lack of data on the volumes of contrast used for the catheterizations, which were not recorded. However, note that all the patients received the same type of contrast agent, the lowest possible amounts of contrast were used and no excess use was reported in any of the patients. Since the quantity and type of contrast used did not vary, it is possible that these were not influential factors in this study.
This study has important clinical implications and can guide surgeons on the timing of surgery after cardiac catheterization. First, in emergency and urgent cases, surgery can be performed safely with appropriate precautions, and it should not be delayed to decrease the risk of postoperative renal dysfunction. These precautions should include optimization of preoperative haematocrit levels; maintenance of adequate haematocrit and mean arterial pressure during CPB and use of meticulous surgical techniques to minimize the duration of CPB, perioperative bleeding and requirements for blood transfusion. Even in elderly patients, patients with LVD and patients with increased creatinine level, the timing between angiography and surgery was not found to be a risk factor for AKI, and early surgery can be recommended in clinically unstable patients. Secondly, since Group C included a greater number of patients with increased risk of AKI, optimizing renal functions preoperatively in stable patients may be an appropriate strategy. Although the guideline recommends withholding surgery only in patients with chronic renal dysfunction, we believe that it would also be useful to withhold the intervention for the optimization of renal functions in high-risk patients ( particularly in older patients and in those with high BMI and low preoperative haematocrit levels) and in patients undergoing CPB of a possibly longer duration.
In conclusion, our results do not support the a priori hypothesis of the additive risk of cardiac catheterization and CPB on the development of postoperative AKI, when these procedures are performed in close succession. According to various reports, the axiomatic concept of the 'recovery period' of the kidneys after exposure to contrast is widely accepted and further insults on the functional reserve of the kidneys should be avoided in this interim period of 10 days. However, our results showed that surgery may be considered 'safe' on any day after catheterization, if influential factors other than time are accounted for when planning cardiac surgery, in order to prevent postoperative renal complications.
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